Question to the Department of Health and Social Care:

To ask His Majesty's Government whether patients with a cancer diagnosis will have access to local genomic testing; and if so, what is the timeline for that access to be in place.

The 10-Year Health Plan committed to every cancer patient having the choice to receive a comprehensive genomic analysis and molecular profiling, where appropriate. The NHS Genomic Medicine Service (GMS) ensures equitable access to genomic testing for cancer patients across England through seven regional GMS geographies working with Cancer Alliances and National Health Service trusts. Genomic testing is delivered by a national network of seven NHS Genomic Laboratory Hubs, guided by the National Genomic Test Directory, which includes over 200 cancer indications for a range of genomic tests, including whole genome sequencing. In 2025/26, NHS England is continuing its Cancer Genomics Improvement Programme for a second year to deliver quality improvement initiatives, education, local engagement, and to establish Cellular Pathology Genomic Centres to streamline cancer genomics pathways and accelerate genomic testing.